Yüklüyor......
Serum sRANKL and sRANKL/OPG ratio: Novel biomarkers in non-small cell lung cancer
Osteoprotegerin (OPG) and soluble receptor activator of nuclear factor-κB ligand (sRANKL) are bone-regulating molecules. The two molecules have each been indicated to be involved in carcinogenesis. However, the diagnostic significance in non-small cell lung cancer (NSCLC) remains to be investigated....
Kaydedildi:
| Yayımlandı: | Oncol Lett |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
D.A. Spandidos
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4774468/ https://ncbi.nlm.nih.gov/pubmed/26998159 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.4166 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|